OTHER CURRENT LIABILITIES (Tables)

3 Months Ended

Mar. 31, 2024

Other Liabilities Disclosure [Abstract]

SCHEDULE OF OTHER CURRENT LIABILITIES

Other current liabilities consisted of the following:

	March 31, 2024		December 31, 2023
Accrued research and development expenses (including clinical trial accrued expenses)	$	1,570	$	2,018
Accrued professional fees		1,815		1,674
Payroll and employee-related costs		1,972		1,934
Deferred funding		3,166		3,601
Other current liabilities		1,005		1,057
	$	9,528	$	10,284